0000899243-17-012254.txt : 20170508 0000899243-17-012254.hdr.sgml : 20170508 20170508171455 ACCESSION NUMBER: 0000899243-17-012254 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170504 FILED AS OF DATE: 20170508 DATE AS OF CHANGE: 20170508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robb Gary Charles CENTRAL INDEX KEY: 0001529655 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 17823415 MAIL ADDRESS: STREET 1: C/O 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-04 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001529655 Robb Gary Charles C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 Chief Financial Officer Common Stock 2017-05-04 4 P 0 5600 9.7479 A 6858 D Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $9.7470 to $9.7499 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request. /s/ Gary Charles Robb 2017-05-08